Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ally Bridge Group

Investor type Private Equity Firm
Founders Frank Yu


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 64
Average round size
The average size of a deal this fund participated in
Portfolio companies 50
Rounds per year 7.11
Lead investments 10
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 18
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Pharmaceutical
  • Medical

In 2013 was created Ally Bridge Group, which is appeared as VC. The main office of represented VC is situated in the Hong Kong. The company was established in Asia in Hong Kong.

Among the various public portfolio startups of the fund, we may underline TESARO, GRAIL, Innovent Biologics Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Ally Bridge Group works on 0 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2018. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 50 - 100 millions dollars are the general things for fund. The average startup value when the investment from Ally Bridge Group is 500 millions - 1 billion dollars.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Ally Bridge Group, startups are often financed by New Enterprise Associates, Kleiner Perkins, F-Prime Capital. The meaningful sponsors for the fund in investment in the same round are Rock Springs Capital, New Enterprise Associates, Hillhouse Capital Group. In the next rounds fund is usually obtained by Venrock, T. Rowe Price, Sofinnova Partners.

This organization was formed by Frank Yu. The overall number of key employees were 3.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ally Bridge Group:
Typical Co-investors
Ally Bridge Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ally Bridge Group:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acrodea Japan, Minato
AllBright England, London, United Kingdom
Earl Grey Capital -
Ecosystem Integrity Fund California, San Francisco, United States
Florida Gulfshore Capital Florida, Naples, United States
Franciscan Sisters of Mary Bridgeton, Missouri, United States
GlobalFoundries California, Santa Clara, United States
Ju Shi Chuang Tou China, Jiangsu, Nanjing
Kitty Hawk California, Mountain View, United States
Kogito Ventures Mazowieckie, Poland, Warsaw
KT Squared -
Myventure Partners Seoul, Seoul-t'ukpyolsi, South Korea
Oak Hill Advisors New York, New York, United States
Presight Capital New City, New York, United States
SierraMaya360 California, Los Angeles, United States
Sodero Gestion France, Nantes, Pays de la Loire
Startupbootcamp Amsterdam Amsterdam, Noord-Holland, The Netherlands
US Ecology Boise, Idaho, United States
Virginia Active Angel Network Charlottesville, United States, Virginia
ZM Invest Podkarpackie, Poland, Ropczyce

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CG Oncology

Health Care
Health Diagnostics
$120M15 Nov 2022 Irvine, California, United States


Health Care
Health Diagnostics
Medical Device
$50M21 Sep 2022 Mountain View, California, United States


Health Care
Medical Device
$160M13 Sep 2022 San Diego, California, United States


Big Data
Cloud Computing
Health Care
Information Services
Information Technology
$35M27 Jul 2022 San Francisco, California, United States

Aerin Medical

Health Care
Medical Device
$60M16 Jun 2022 Sunnyvale, California, United States

Endeavor BioMedicines

$101M07 Feb 2022 California, United States

Quantum Surgical

Health Care
Medical Device
$47M19 Oct 2021 France, Auvergne-Rhône-Alpes, France

Elligo Health Research

Health Care
$135M24 Sep 2021 Austin, Texas, United States

Imperative Care

Health Care
Medical Device
$260M15 Jul 2021 California, United States
Elligo Health Research Inks $135M Series E

– Elligo Health Research, a healthcare-enabling research organization powered by the novel IntElligo technology, announced a $135m Series E financing round.
Morgan Stanley Expansion Capital and Ally Bridge Group participated in the financing round.
– The round was also participated by Norwest Venture Partners and all major existing investors, including Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, and Syneos Health.
– This financing allows Elligo to invest further in its technology platform and leverage data in new ways to address current challenges in the clinical trial industry.

Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care

– Imperative Care, Inc. announced that it has closed a $260m Series D financing led by D1 Capital Partners.
– New investors HealthCor Investments LLC and Innovatus Capital Partners also joined the round. Existing Imperative Care investors Ally Bridge Group, Bain Capital Life Sciences, Ascension Ventures, Delos Capital, Rock Springs Capital, and Amed Ventures participated in the financing.
– James Rogers from D1 will join Imperative Care’s Board of Directors.
– Proceeds from the financing will be used to support ongoing commercialization and development of a wide range of Imperative Care’s technologies in the broad continuum of stroke care, as well as to create a strategic network of wholly owned development subsidiaries in a number of areas of synergy.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ally Bridge Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: